Market Tracker

06/29 5:16pm ET

DexCom Inc (NASDAQ:DXCM)

79.00
Delayed Data
As of 4:00pm ET
 +0.96 / +1.23%
Today’s Change
47.92
Today|||52-Week Range
103.29
-3.54%
Year-to-Date
Weekly CFO Sells Highlights
Jun 28 / GuruFocus News - Paid Partner Content
Diabetes Deep-Dive: What Investors Need to Know About This Devastating Disease
Jun 18 / MotleyFool.com - Paid Partner Content
Weekly CFO Sells Highlight
Jun 28 / GuruFocus News - Paid Partner Content
Getting OLD but want to be SLIM? There are ETFs for that
Jun 09 / CNNMoney.com
The Next Big Thing in Diabetes Treatment May Not Be a Drug, But a Device
Jun 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close78.04
Today’s open78.01
Day’s range78.01 - 81.23
Volume1,261,454
Average volume (3 months)878,593
Market cap$6.5B
Dividend yield--
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-140.00%
Earnings growth (this year)-37.78%
Earnings growth (next 5 years)+32.50%
Revenue growth (last year)+55.09%
P/E ratioNM
Price/Sales16.26
Price/Book28.82

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.24+0.32%
ABMDAbiomed Inc+3.07+2.92%
NUVANuVasive Inc+0.50+0.85%
IARTIntegra LifeSciences...+1.82+2.39%
Data as of 4:02pm ET, 06/29/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$402.0M
Annual profit (last year)-$57.6M
Net profit margin-14.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts